Light Degradable Drug Delivery System For Effective Ocular Therapy
- Detailed Technology Description
- University researchers have developed compositions and methods that enable light-triggered ocular drug delivery utilizing a polymer that degrades upon exposure to specific wavelength(s) of light.
- Supplementary Information
- Inventor: ALMUTAIRI, Adah | ALMUTAIRI, Khalid
Priority Number: WO2013169955A1
IPC Current: A61N000500 | A61B001804 | B82Y000500
Assignee Applicant: The Regents of the University of California
Title: FINE SPATIOTEMPORAL CONTROL OF THERMOLYSIS AND LIPOLYSIS USING NIR LIGHT | RÉGLAGE SPATIO-TEMPOREL FIN DE LA THERMOLYSE ET DE LA LIPOYSE AU MOYEN D'UNE LUMIÈRE INFRAROUGE PROCHE
Usefulness: FINE SPATIOTEMPORAL CONTROL OF THERMOLYSIS AND LIPOLYSIS USING NIR LIGHT | RÉGLAGE SPATIO-TEMPOREL FIN DE LA THERMOLYSE ET DE LA LIPOYSE AU MOYEN D'UNE LUMIÈRE INFRAROUGE PROCHE
Summary: System for minimally-invasive lipolysis in a target area to remove fatty tissue using infrared laser light for a patient.
Novelty: System for minimally-invasive lipolysis in target area to remove of fatty tissue using infrared laser light for patient, has emission wavelength adapted to excite biocompatible nanoparticles to melt fat within target area
- Industry
- Disease Diagnostic/Treatment
- Sub Category
- Other Disease
- Others
-
State Of Development
Proof of concept has been achieved through in vitro and in vivo experiments.
Intellectual Property Info
The invention has a patent pending and is available for licensing.
Related Cases
Tech ID/UC Case
23225/2012-355-0
Related Cases
2012-355-0
- *Abstract
-
None
- *Principal Investigator
-
Name: Adah Almutairi
Department:
Name: Enas Mahmoud
Department:
Name: Cathryn McFearin
Department:
Name: Nguyen Huu
Department:
- Country/Region
- USA
For more information, please click Here
